Mycobacterium tuberculosis adapts to the low-glucose conditions in its host by using lipids as a fuel source. This adaptation reveals a weak flank that might be exploited in drug development, as shown in work on mice and human cells (pages 638–644).
References
Muñoz-Elías, E.J. & McKinney, J.D. Nat. Med. 11, 638–644 (2005).
Hingley-Wilson, S.M., Sambandamurthy, V.K. & Jacobs, W.R., Jr. Nat. Immunol. 4, 949–955 (2003).
De Voss, J.J. et al. Proc. Natl. Acad. Sci. USA 97, 1252–1257 (2000).
Liu, K., Yu, J. & Russell, D.G. Microbiology 149, 1829–1835 (2003).
Cole, S.T. et al. Nature 393, 537–544 (1998).
Timm, J. et al. Proc. Natl. Acad. Sci. USA 100, 14321–14326 (2003).
Schnappinger, D. et al. J. Exp. Med. 198, 693–704 (2003).
Lorenz, M.C. & Fink, G.R. Eukaryot. Cell 1, 657–662 (2002).
Idnurm, A. & Howlett, B.J. Eukaryot. Cell 1, 719–724 (2002).
Wang, Z.Y., Thornton, C.R., Kershaw, M.J., Debao, L. & Talbot, N.J. Mol. Microbiol. 47, 1601–1612 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boshoff, H., Barry, C. A low-carb diet for a high-octane pathogen. Nat Med 11, 599–600 (2005). https://doi.org/10.1038/nm0605-599
Issue Date:
DOI: https://doi.org/10.1038/nm0605-599
- Springer Nature America, Inc.
This article is cited by
-
A rheostat mechanism governs the bifurcation of carbon flux in mycobacteria
Nature Communications (2016)
-
Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosis
BMC Systems Biology (2010)